References
- Araf Y, Akter F, TangY-D, et al. Omicron variant of SARS-CoV-2: genomics, transmissibility, and responses to current COVID-19 vaccines. J Med Virol. 2022;94(5):1825–1832. doi:10.1002/jmv.27588
- Classification of Omicron (B.1.1.529): SARS-CoV-2 variant of concern. Available from: https://www.who.int/news/item/26-11-2021-classification-of-omicron-(b.1.1.529)-sars-cov-2-variant-of-concern. Accessed December 3, 2022.
- Torjesen I. Covid-19: omicron may be more transmissible than other variants and partly resistant to existing vaccines, scientists fear. BMJ. 2021;n2943. doi:10.1136/bmj.n2943
- Cele S, Jackson L, Khoury DS, et al. Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization. Nature. 2022;602(7898):654–656. doi:10.1038/s41586-021-04387-1
- Chen J, Wang R, Gilby NB, Wei GW. Omicron variant (B.1.1.529): infectivity, vaccine breakthrough, and antibody resistance. J Chem Inf Model. 2022;62(2):412–422. doi:10.1021/acs.jcim.1c01451
- Morita S, Nakagawa K. Evaluating the impact of human flow on the spread of infectious diseases. J Theor Biol. 2023;558:111367. doi:10.1016/j.jtbi.2022.111367
- Health and climate change: country profile 2021: israel. Available from: https://www.who.int/publications-detail-redirect/WHO-HEP-ECH-CCH-22.01.06. Accessed November 30, 2022.
- Country statistical profile: israel 2022/4 | country statistical profiles: key tables from OECD | OECD iLibrary. Available from: https://www.oecd-ilibrary.org/economics/country-statistical-profile-israel-2022-4_f4d0bd25-en. Accessed December 12, 2022.
- Singapore Department of Statistics (DOS). Base. Available from: http://www.singstat.gov.sg/. Accessed December 3, 2022.
- Division UNP. United Nation|By Location | pivot Table | data Portal|Population density. Population Division Data Portal. Available from: https://population.un.org/dataportal/data/indicators/54/locations/376/start/2020/end/2023/table/pivotbylocation. Accessed February 18, 2023.
- SunG-Q, ZhangH-T, Chang-L-L, Jin Z, Wang H, Ruan S. On the dynamics of a diffusive foot-and-mouth disease model with nonlocal infections. SIAM J Appl Math. 2022;82(4):1587–1610. doi:10.1137/21M1412992
- Kuguyo O, Kengne AP, Dandara C. Singapore COVID-19 pandemic response as a successful model framework for low-resource health care settings in Africa? Omics J Integr Biol. 2020;24(8):470–478. doi:10.1089/omi.2020.0077
- Last M. The first wave of COVID-19 in Israel-Initial analysis of publicly available data. PLoS One. 2020;15(10):e0240393. doi:10.1371/journal.pone.0240393
- Muhsen K, Na’aminh W, Lapidot Y, et al. A nationwide analysis of population group differences in the COVID-19 epidemic in Israel, February 2020–February 2021. Lancet Reg Health - Eur. 2021;7:100130. doi:10.1016/j.lanepe.2021.100130
- Delavari S, Jamali Z, Bayati M. Lockdown effect on COVID-19 incidence and death: Iran experience. Disaster Med Public Health Prep. 2021;1–3. doi:10.1017/dmp.2021.222
- Czypionka T, Iftekhar EN, Prainsack B, et al. The benefits, costs and feasibility of a low incidence COVID-19 strategy. Lancet Reg Health Eur. 2022;13:100294. doi:10.1016/j.lanepe.2021.100294
- Bolzoni L, Bonacini E, Della marca R, Groppi M. Optimal control of epidemic size and duration with limited resources. Math Biosci. 2019;315:108232. doi:10.1016/j.mbs.2019.108232
- Singapore Ministry of Health. Available from: https://www.moh.gov.sg/. Accessed February 16, 2023.
- Israel Ministry of Health. Available from: https://datadashboard.health.gov.il/COVID-19/general. Accessed February 16, 2023.
- Mathieu E, Ritchie H, Rodés-Guirao L, et al. Coronavirus Pandemic (COVID-19). Our World Data; 2020. Available from: https://ourworldindata.org/coronavirus. Accessed December 4, 2022.
- COVID-19 Symptoms. Corona Traffic Light Model (Ramzor) Website. Available from: https://corona.health.gov.il/en/confirmed-cases-and-patients/common-symptoms/. Accessed February 14, 2023.
- Israel services and government information website. Available from: https://www.gov.il/en. Accessed February 20, 2023.
- Singapore Government Agency Website. Available from: https://www.gov.sg/. Accessed February 16., 2023.
- Living normally, with Covid-19: task force ministers on how S’pore is drawing road map for new normal | the Straits Times. Available from: https://www.straitstimes.com/opinion/living-normally-with-covid-19. Accessed February 16, 2023.
- Green Pass and Purple Badge Restrictions Lifted – public Updates and Guidance. GOV.IL. Available from: https://www.gov.il/en/departments/news/01062021-01. Accessed February 16., 2023.
- Gwee SXW, Chua PEY, Wang MX, Pang J. Impact of travel ban implementation on COVID-19 spread in Singapore, Taiwan, Hong Kong and South Korea during the early phase of the pandemic: a comparative study. BMC Infect Dis. 2021;21(1):799. doi:10.1186/s12879-021-06449-1
- Jiao J, Shi L, Chen H, et al. Containment strategy during the COVID-19 pandemic among three Asian low and middle-income countries. J Glob Health. 2022;12:05016. doi:10.7189/jogh.12.05016
- Haas EJ, Angulo FJ, McLaughlin JM, et al. Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data. Lancet Lond Engl. 2021;397(10287):1819–1829. doi:10.1016/S0140-6736(21)00947-8
- Nyberg T, Ferguson NM, Nash SG, et al. Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study. Lancet Lond Engl. 2022;399(10332):1303–1312. doi:10.1016/S0140-6736(22)00462-7
- Pérez-Then E, Lucas C, Monteiro VS, et al. Neutralizing antibodies against the SARS-CoV-2 Delta and Omicron variants following heterologous CoronaVac plus BNT162b2 booster vaccination. Nat Med. 2022;28(3):481–485. doi:10.1038/s41591-022-01705-6
- Andrews N, Stowe J, Kirsebom F, et al. Covid-19 vaccine effectiveness against the Omicron (B.1.1.529) variant. N Engl J Med. 2022;386(16):1532–1546. doi:10.1056/NEJMoa2119451
- Leshem E, Wilder-Smith A. COVID-19 vaccine impact in Israel and a way out of the pandemic. Lancet. 2021;397(10287):1783–1785. doi:10.1016/S0140-6736(21)01018-7
- Yang M, Shi L, Chen H, et al. Comparison of COVID-19 vaccine policies in Italy, India, and South Africa. Vaccines. 2022;10(9):1554. doi:10.3390/vaccines10091554
- Vuong QH, Le TT, La VP, et al. Covid-19 vaccines production and societal immunization under the serendipity-mindsponge-3D knowledge management theory and conceptual framework. Humanit Soc Sci Commun. 2022;9(1):1–12. doi:10.1057/s41599-022-01034-6
- Rossman H, Meir T, Somer J, et al. Hospital load and increased COVID-19 related mortality in Israel. Nat Commun. 2021;12(1):1904. doi:10.1038/s41467-021-22214-z
- Global Health Expenditure Database. Available from: https://apps.who.int/nha/database/ViewData/Indicators/en. Accessed December 12, 2022.
- Chen H, Shi L, Zhang Y, et al. Response to the COVID-19 pandemic: comparison of strategies in six countries. Front Public Health. 2021;9:708496. doi:10.3389/fpubh.2021.708496
- Zou H, Guo Y, Hu M, Ding J, Zheng N, Lu J. Construction and enlightenment of Israel′s medical and health care risk prevention system. Chin J Hosp Adm. 2019;11:966–967–968. doi:10.3760/cma.j.issn.1000-6672.2019.11.020
- Shapiro Ben David S, Cohen D, Karplus R, et al. COVID-19 community care in Israel-a nationwide cohort study from a large health maintenance organization. J Public Health Oxf Engl. 2021;43(4):723–730. doi:10.1093/pubmed/fdab055
- Pei S, Kandula S, Shaman J. Differential effects of intervention timing on COVID-19 spread in the United States. MedRxiv Prepr Serv Health Sci. 2020. doi:10.1101/2020.05.15.20103655
- Asamoah JKK, Okyere E, Abidemi A, et al. Optimal control and comprehensive cost-effectiveness analysis for COVID-19. Results Phys. 2022;33:105177. doi:10.1016/j.rinp.2022.105177
- Das P, Upadhyay RK, Misra AK, Rihan FA, Das P, Ghosh D. Mathematical model of COVID-19 with comorbidity and controlling using non-pharmaceutical interventions and vaccination. Nonlinear Dyn. 2021;106(2):1213–1227. doi:10.1007/s11071-021-06517-w
- Ma X, Luo XF, Li L, Li Y, Sun GQ. The influence of mask use on the spread of COVID-19 during pandemic in New York City. Results Phys. 2022;34:105224. doi:10.1016/j.rinp.2022.105224
- COVID-19 Containment and Health Index. Our World in Data. Available from: https://ourworldindata.org/grapher/covid-containment-and-health-index. Accessed February 16, 2023.
- O’Driscoll M, Ribeiro Dos Santos G, Wang L, et al. Age-specific mortality and immunity patterns of SARS-CoV-2. Nature. 2021;590(7844):140–145. doi:10.1038/s41586-020-2918-0
- Imam T, Uddin S. How do economic and public finance statuses affect policy responses during a pandemic? - learning from the COVID-19 first wave. BMC Public Health. 2022;22(1):785. doi:10.1186/s12889-022-13209-6
- Sheridan C, Klompmaker J, Cummins S, James P, Fecht D, Roscoe C. Associations of air pollution with COVID-19 positivity, hospitalisations, and mortality: observational evidence from UK Biobank. Environ Pollut Barking Essex. 2022;308:119686. doi:10.1016/j.envpol.2022.119686
- Gozum IE, Capulong HG, Gopez JM, Galang JR. Culture, religion and the state: towards a multidisciplinary approach to ensuring public health during the COVID-19 pandemic (and beyond). Risk Manag Healthc Policy. 2021;14:3395–3401. doi:10.2147/RMHP.S318716